
Russia ready to export Avifavir for treatment of coronavirus amid global shortage

-
01:00
-
03 July 2020
Russian Direct Investment Fund (RDIF) is ready to export Avifavir drug against the coronavirus amid the shortage of such drugs globally due to the US authorities’ decision to purchase almost 100% of the manufactured Remdesivir in the coming months, the Fund said in a statement on Thursday, APA reports citing TASS.
Moreover, RDIF and ChemRar produced the first 100,000 courses of Avifavir in June, significantly exceeding initially planned production levels of 60,000 courses, the statement said.
In June, the drug was delivered across Russia's 35 regions and to the Republic of Belarus. Agreement has also been reached for deliveries of Avifavir to the Republic of Kazakhstan in the near future. In total, more than 100,000 courses will be produced in July.